What is a waiver of informed consent? Waiver of Documentation of Informed Consent (45 CFR 46.117) This means that the study team must provide a subject with the required consent information, but the study team is not required to obtain the subject's signature on the informed consent document. What is a waiver in clinical trials? A Protocol Waiver may be defined as the sponsor approval for a prospective protocol deviation. Such deviations can often involve (but may not be limited to) the active recruitment to a study of one or more participants who do not meet the inclusion/exclusion criteria as detailed in the study protocol. What is the criteria for waiver of documentation of informed consent? For research that is FDA-regulated, a waiver of documentation of consent may be granted only: When the research presents no more than minimal risk of harm to participants and involves no procedures for which written consent is normally required outside the research context. What is the difference between a waiver and informed consent? A waiver is legal document releasing or relinquishing a known right, claim, or privilege. In this context, it is the relinquishment to pursue a claim in a certain set of defined circumstances. Informed consent is a written acknowledgement that a participant understands the risks inherent in a particular activity. Inform consent:- A process by which a subject voluntarily confirms his or her willingness to participate in a particular trial, after having been informed of all aspects of the trial that are relevant to the subject’s decision to participate Inform consent Waiver:- It is a process in which informed consent is not obtained from subjects, or that eliminates or alters some (or all) of the elements of informed consent as set forth in Federal regulations (45 CFR 46.116d) The IRB must ensure that the following 4 criteria are met prior to approving a waiver or alteration of consent: The research poses no more than minimal risk to subjects The research does not adversely affect the rights and welfare The research not practicable without the waiver Whenever appropriate. The subject will be provided with pertinent information after participation Siro Clinical Research Institute. www.siroinstitute.com Post Graduate Diploma in Clinical Research. Pharmacovigilance, Clinical Trials, Clinical Data Management, Clinical Operation, Medical writing. #Pharmacovigilance #CDM #data #Clinicalresearch, #regulatoryaffairs, #medicalcoding, #clinicalSAS #management #health #comment #pune #clinicalresearch #medicaldevices #career #opportunity #oncology #safety #pharmajobs #gpat #pharmacy #mbbs #jobs #jobsearch #training #healthandsafety #nowhiring #healthcare #clinical #opportunities #doctor #medicine #hiring #bpharmajobs #coding #regulatoryaffairs #medical #nursing #clinicalresearch #medicaldevices #career #opportunity #oncology #safety #pharmajobs #gpat #pharmacy #mbbs #jobs #jobsearch # #training #healthandsafety #nowhiring

1. Inform
Consent
Waiver
Presented By :
Manasi Dhamal, Dr. Geetu Mohan,
Adil Shaikh, Aarti Yadgire
www.siroinstitute.com

2. Content
• Introduction
• Criteria for waiver of consent
• Scenarios for possible Waiver
• Follow up consent
• Example for a request for waiver of IC
• Conclusion
• References
SIRO Clinical Research Institute 2
3/6/2023 4:25 AM
www.siroinstitute.com

3. Introduction
 Inform consent:- A process by which a subject voluntarily confirms his
or her willingness to participate in a particular trial, after having been
informed of all aspects of the trial that are relevant to the subject’s
decision to participate
 Inform consent Waiver:- It is a process in which informed consent is
not obtained from subjects, or that eliminates or alters some (or all) of
the elements of informed consent as set forth in Federal regulations (45
CFR 46.116d)
3
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

4. Criteria for waiver of consent (1/5)
The IRB must ensure that the following 4 criteria are met prior to
approving a waiver or alteration of consent:
1. The research poses no more than minimal risk to subjects
2. The research does not adversely affect the rights and welfare
3. The research not practicable without the waiver
4. Whenever appropriate. The subject will be provided with pertinent
information after participation
4
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

5. Criteria for waiver of consent (2/5)
1. The research poses no more than minimal risk to subjects
Describe specifically how the proposed research poses no more than
minimal risk to subjects.
Minimal risk – means the probability and magnitude of harm or
discomfort anticipated in the research are not greater in and of
themselves than those ordinarily encountered in daily life or during the
performance of routine physical or psychological examinations or tests
5
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

6. Criteria for waiver of consent(3/5)
2. The research does not adversely affect the rights and welfare
Describe why the waiver will not adversely affect subjects
Consider the following
• Are tests / procedures being done solely for this research or is data
being collected on past procedures that are completed?
• Could the results of research potentially affect the subjects regular
care?
• Would use of their information affect subjects regular care
• Could participation in the study negatively affect the subjects wellbeing
6
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

7. Criteria for waiver Of consent (4/5)
3. The research not practicable without the waiver
Describe why it would not be feasible to conduct the study without a
waiver or alteration of informed consent
Consider the following
• It is likely that the data being reviewed contain out of data contact
information for subjects?
• Does the number of charts being reviewed make it impractical to
contact each subjects for consent?
• Would identifying and contacting each subject to obtain consent be
prohibitive
7
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

8. Criteria for waiver Of consent (5/5)
4. Whenever appropriate, the subject will be provided with pertinent
information after participation
Describe whether information resulting from the study will be disclosed to
subjects.
Consider the following
• Will the results from the study have any effect on subjects or their
regular care?
• Are there any anticipated benefits that would change care subjects have
already received?
8
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

9. Scenarios for possible Waivers
The FDA only permits an IRB to approve a clinical investigation without
participants informed consent in the following circumstances:-
• Emergency Use
• Exception from informed consent for planned emergency research
• Informed consent for in vitro diagnostic device studies using leftover
human specimens that are not individually identifiable
9
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

10. Follow-up consent(1/2)
In occasional minimal risk studies, the EC may waive consent when
subjects initially cannot consent for themselves, but require consent for
later procedures when subjects recover their capacity to consent.
 Example where follow up consent required :-
The EC approved waiver of consent for a minimal risk blood draw from
patients arriving unconscious at the emergency room.
But if the researcher want any procedures to continue after subjects
become competent to consent or want the subject to participate in follow
up procedures.
10
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

11. Follow up consent (2/2)
 Contents of follow up consent
• The consent form should clearly describe
• What procedures occurred without the subjects consent
• Why they were performed
• What additionally will be done if consent is given to continue the subject in the
study
11
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

12. Example for a request for waiver OF IC (1/5)
• The researcher plans to determine whether some specific blood
chemistry values change in individuals undergoing clinically indicated
abdominal surgery and if there is a correlation of changes with the
increased incidence of complications after surgery.
• Proposed research plan is to:
Review the medical records of all individuals who have undergone
abdominal surgery in the past 2 years.
12
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

13. Example for a request for waiver of IC (2/5)
 Data to be collected
• Diagnosis before surgery
• Type of abdominal surgery
• Specific pre-surgery blood chemistry values
• Specific post-surgery blood chemistry values
• Description of the problems after surgery
• Age range of the individuals.
13
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

14. Example for a request for waiver of IC (3/5)
• From a preliminary estimate, there are about 5,000 abdominal surgeries
per year at the hospital.
• The researcher will double code the data so that only the researcher
knows the link in the unlikely event the data must be verified for
accuracy.
• The results of the research will not affect the clinical care of the
individuals because the information will not be examined until after
subjects leave the hospital.
14
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

15. Example for a request for waiver of IC (4/5)
Sufficient justification for IRB to approve a waiver of informed consent :-
• The research involves minimal risk, as the review of subjects medical
records is for limited information
• The information is not sensitive in nature, and the data are derived from
clinically indicated procedures
15
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

16. Example for a request for waiver of IC(5/5)
• There is an extremely low probability of harm to subjects status
employment, or insurability
• The precaution taken to limit the record review to specified data and
double coding of the data further minimize the major risk, which is
breach of confidentiality
• Contacting subjects to obtain their consent could be considered an
invasion of privacy and cause subjects undue anxiety
16
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

17. Conclusion
Informed consent may be waived in following
 Minimal Risk
• Medical records research
• Observational research on large groups
• Research on tissue/blood samples
 Research in the Emergency setting
• Potential subjects are not competent to give consent at the time of
intervention
• No opportunity to obtain surrogate consent
17
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

18. References
• ICH-GCP E(6) R(2)
• https://irb.ucsf.edu/waiving-informed-consent
18
3/6/2023 4:25 AM
www.siroinstitute.com SIRO Clinical Research Institute

19. Thank you!
www.siroinstitute.com SIRO Clinical Research Institute